ovarian cancer awareness in the uk, page-3

  1. 12,639 Posts.
    Healthlinx said UK distributor Intus Healthcare completed a commercial arrangement with
    hospital and healthcare services group Spire Healthcare to process and market Ovplex.
    The company said the UK market potential was more than 750,000 units potentially worth
    more than $5 million.



    My comment:- I don't get it. This article is saying that the UK market potential is only worth a little over 5 million.

    Thats not alot of revenue??
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.